6cqf
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==Crystal structure of HPK1 in complex an inhibitor G1858== | |
+ | <StructureSection load='6cqf' size='340' side='right' caption='[[6cqf]], [[Resolution|resolution]] 2.25Å' scene=''> | ||
+ | == Structural highlights == | ||
+ | <table><tr><td colspan='2'>[[6cqf]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6CQF OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6CQF FirstGlance]. <br> | ||
+ | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=F97:N-{2-(3,3-difluoropyrrolidin-1-yl)-6-[(3R)-pyrrolidin-3-yl]pyrimidin-4-yl}-1-(propan-2-yl)-1H-pyrazolo[4,3-c]pyridin-6-amine'>F97</scene></td></tr> | ||
+ | <tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Non-specific_serine/threonine_protein_kinase Non-specific serine/threonine protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.1 2.7.11.1] </span></td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6cqf FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6cqf OCA], [http://pdbe.org/6cqf PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6cqf RCSB], [http://www.ebi.ac.uk/pdbsum/6cqf PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6cqf ProSAT]</span></td></tr> | ||
+ | </table> | ||
+ | == Function == | ||
+ | [[http://www.uniprot.org/uniprot/M4K1_HUMAN M4K1_HUMAN]] Serine/threonine-protein kinase, which may play a role in the response to environmental stress. Appears to act upstream of the JUN N-terminal pathway. May play a role in hematopoietic lineage decisions and growth regulation. Able to autophosphorylate.<ref>PMID:24362026</ref> <ref>PMID:8824585</ref> | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | Enhancement of antigen-specific T cell immunity has shown significant therapeutic benefit in infectious diseases and cancer. Hematopoietic progenitor kinase-1 (HPK1) is a negative-feedback regulator of T cell receptor signaling, which dampens T cell proliferation and effector function. A recent report showed that a catalytic dead mutant of HPK1 phenocopies augmented T cell responses observed in HPK1-knockout mice, indicating that kinase activity is critical for function. We evaluated active and inactive mutants and determined crystal structures of HPK1 kinase domain (HPK1-KD) in apo and ligand bound forms. In all structures HPK1-KD displays a rare domain-swapped dimer, in which the activation segment comprises a well-conserved dimer interface. Biophysical measurements show formation of dimer in solution. The activation segment adopts an alpha-helical structure which exhibits distinct orientations in active and inactive states. This face-to-face configuration suggests that the domain-swapped dimer may possess alternative selectivity for certain substrates of HPK1 under relevant cellular context. | ||
- | + | Hematopoietic Progenitor Kinase-1 Structure in a Domain-Swapped Dimer.,Wu P, Sneeringer CJ, Pitts KE, Day ES, Chan BK, Wei B, Lehoux I, Mortara K, Li H, Wu J, Franke Y, Moffat JG, Grogan JL, Heffron TP, Wang W Structure. 2018 Nov 13. pii: S0969-2126(18)30386-1. doi:, 10.1016/j.str.2018.10.025. PMID:30503777<ref>PMID:30503777</ref> | |
- | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
- | + | </div> | |
- | [[Category: | + | <div class="pdbe-citations 6cqf" style="background-color:#fffaf0;"></div> |
- | [[Category: Chan, B | + | == References == |
- | + | <references/> | |
+ | __TOC__ | ||
+ | </StructureSection> | ||
+ | [[Category: Non-specific serine/threonine protein kinase]] | ||
+ | [[Category: Chan, B K]] | ||
[[Category: Franke, Y]] | [[Category: Franke, Y]] | ||
- | [[Category: Mortara, K]] | ||
[[Category: Lehoux, I]] | [[Category: Lehoux, I]] | ||
+ | [[Category: Mortara, K]] | ||
+ | [[Category: Wang, W]] | ||
+ | [[Category: Wu, P]] | ||
+ | [[Category: Protein kinase]] | ||
+ | [[Category: Transferase-transferase inhibitor complex]] |
Revision as of 08:18, 19 December 2018
Crystal structure of HPK1 in complex an inhibitor G1858
|